摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

ethyl 4-(5-cyanopyridin-2-yl)butanoate | 1100766-40-2

中文名称
——
中文别名
——
英文名称
ethyl 4-(5-cyanopyridin-2-yl)butanoate
英文别名
——
ethyl 4-(5-cyanopyridin-2-yl)butanoate化学式
CAS
1100766-40-2
化学式
C12H14N2O2
mdl
——
分子量
218.255
InChiKey
BRTVKBPILOJQIO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    350.4±37.0 °C(Predicted)
  • 密度:
    1.12±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.4
  • 重原子数:
    16
  • 可旋转键数:
    6
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.42
  • 拓扑面积:
    63
  • 氢给体数:
    0
  • 氢受体数:
    4

反应信息

  • 作为反应物:
    描述:
    ethyl 4-(5-cyanopyridin-2-yl)butanoate 、 sodium hydroxide 作用下, 以 四氢呋喃乙醇 为溶剂, 生成 4-(5-cyanopyridin-2-yl)butanoic acid
    参考文献:
    名称:
    Synthesis of novel tetrahydroisoquinoline bronchodilators
    摘要:
    The synthesis and bronchorelaxing effects of a series of novel tetrahydroisoquinoline amides are described. The compounds were evaluated for their ability to relax LTD4 contracted isolated human small airways ex-vivo. Several compounds demonstrated highly efficacious bronchorelaxing properties. Cinnamide 71 was selected for further studies and constitutes a promising candidate as a novel bronchorelaxing agent for the treatment of pulmonary disorders. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.07.057
  • 作为产物:
    描述:
    bromo(4-ethoxy-4-oxobutyl)zinc2-溴-5-氰基吡啶 在 [1,3-bis(2,6-diisopropyl-phenyl)imidazol-2-ylidene](3-chloropyridyl)-palladium(II) dichloride 作用下, 以 四氢呋喃 为溶剂, 反应 48.0h, 以80%的产率得到ethyl 4-(5-cyanopyridin-2-yl)butanoate
    参考文献:
    名称:
    Synthesis of novel tetrahydroisoquinoline bronchodilators
    摘要:
    The synthesis and bronchorelaxing effects of a series of novel tetrahydroisoquinoline amides are described. The compounds were evaluated for their ability to relax LTD4 contracted isolated human small airways ex-vivo. Several compounds demonstrated highly efficacious bronchorelaxing properties. Cinnamide 71 was selected for further studies and constitutes a promising candidate as a novel bronchorelaxing agent for the treatment of pulmonary disorders. (C) 2010 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2010.07.057
点击查看最新优质反应信息

文献信息

  • [EN] NOVEL BRONCHODILATING ISOQUINOLINE AMIDES<br/>[FR] NOUVEAUX AMIDES D'ISOQUINOLÉINE BRONCHODILATATEURS
    申请人:RESPIRATORIUS AB
    公开号:WO2009007418A1
    公开(公告)日:2009-01-15
    The invention relates to novel compounds having the general formula I, and which compounds are useful to manufacture a medicament to treat a disorder or disease characterized by bronchoconstriction, e.g. COPD and asthma, and vasoconstriction, e.g. hypertension.
    该发明涉及具有一般式I的新化合物,这些化合物可用于制造用于治疗由支气管痉挛引起的紊乱或疾病的药物,例如慢性阻塞性肺疾病(COPD)和哮喘,以及由血管收缩引起的疾病,例如高血压。
查看更多